Category: Biotechnology
Biotechnology market research reports by DelveInsight
-
Gene Therapies for Cardiomyopathies – Market Insight, Epidemiology, and Market Forecast – 2034
Gene Therapies for Cardiomyopathies – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Gene Therapies for Cardiomyopathies – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Gene Therapies for Cardiomyopathies, hist ... Read More
-
Nucleic Acid and Gene Therapies in Neuromuscular Disorders – Market Insight, Epidemiology, and Market Forecast – 2034
Nucleic Acid and Gene Therapies in Neuromuscular Disorders – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Nucleic Acid and Gene Therapies in Neuromuscular Disorders – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of ... Read More
-
20s Proteasome Inhibitor - Pipeline Insight, 2024
20s Proteasome Inhibitor - Pipeline Insight, 2024 “20s Proteasome Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 20s Proteasome Inhibitor development. The report provides d ... Read More
-
CAR T-cell Therapy - Pipeline Insight, 2024
CAR T-cell Therapy - Pipeline Insight, 2024 DelveInsight’s, “CAR T-cell Therapy - Pipeline Insight, 2024” report provides comprehensive insights about 300+ companies and 300+ pipeline drugs in CAR T-cell Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclin ... Read More
-
Neo Antigen T-cell Therapy - Pipeline Insight, 2024
Neo Antigen T-cell Therapy - Pipeline Insight, 2024 Neo Antigen T-cell Therapy Overview ""Neo Antigen T-cell Therapy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Neo Antigen T-cell Therapy mark ... Read More
-
CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024
CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Multiple Myeloma pipeline landscape. It cover ... Read More
-
Olpasiran Market Size, Forecast, and Emerging Insight − 2032
Olpasiran Market Size, Forecast, and Emerging Insight − 2032 “Olpasiran Market Size, Forecast, and Emerging Insight − 2032” report provides comprehensive insights about olpasiran for myocardial infarction in the seven major markets. A detailed picture of the olpasiran for myocardial infarction in th ... Read More
-
Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024
Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024 Acute Lymphoblastic Leukemia (ALL) Overview ""Acute Lymphoblastic Leukemia (ALL) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute L ... Read More
-
Anti-CD80 Antibody - Pipeline Insight, 2024
Anti-CD80 Antibody - Pipeline Insight, 2024 “Anti-CD80 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD80 Antibody development. The report provides detailed coverage o ... Read More
-
Antibody-Mediated Graft Rejection - Pipeline Insight, 2024
Antibody-Mediated Graft Rejection - Pipeline Insight, 2024 Antibody-Mediated Graft Rejection Overview ""Antibody-Mediated Graft Rejection Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Antibody-M ... Read More
-
Anti-CD37 Antibody - Pipeline Insight, 2024
Anti-CD37 Antibody - Pipeline Insight, 2024 “Anti-CD37 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024 “Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody developmen ... Read More
-
Anti-CD152 Antibody - Pipeline Insight, 2024
Anti-CD152 Antibody - Pipeline Insight, 2024 “Anti-CD152 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD152 Antibody development. The report provides detailed coverag ... Read More
-
G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024
G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024 “G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across G-Protein Coupled Recepto ... Read More
-
Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) - Pipeline Insight, 2024
Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) - Pipeline Insight, 2024 Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) Overview ""Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present ... Read More
-
Allogenic Cell Therapies - Pipeline Insight, 2024
Allogenic Cell Therapies - Pipeline Insight, 2024 Allogenic Cell Therapies Overview ""Allogenic Cell Therapies Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Allogenic Cell Therapies market. A de ... Read More
-
Alpha-1 Protease Inhibitor Deficiency - Pipeline Insight, 2024
Alpha-1 Protease Inhibitor Deficiency - Pipeline Insight, 2024 Alpha-1 Protease Inhibitor Deficiency Overview ""Alpha-1 Protease Inhibitor Deficiency Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across th ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2024
Anti GM-CSF Antibody - Pipeline Insight, 2024 “Anti GM-CSF Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed cove ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024 “Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The repor ... Read More
-
Anti-CD19 Antibody - Pipeline Insight, 2024
Anti-CD19 Antibody - Pipeline Insight, 2024 “Anti-CD19 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD19 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024 “Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report p ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2024
Anti-CD52 Antibody - Pipeline Insight, 2024 “Anti-CD52 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage o ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Acute Lymphoblastic L ... Read More
-
CRISPR therapies - Pipeline Insight, 2024
CRISPR therapies - Pipeline Insight, 2024 DelveInsight’s, “CRISPR Therapies – Pipeline Insight, 2024,” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More
-
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024 “Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutic ... Read More
Research Assistance
